SCHEMBL8732508

SCHEMBL8732508

CCCCCCP(=O)(COc1ccc(C[C@@H](C)N)cc1)OCCCC

nearest known ligand 0.60

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 7/20 0.43
S1PR3 Q99500 6/20 0.43
S1PR4 O95977 5/20 0.43
S1PR5 Q9H228 5/20 0.43
S1PR2 O95136 3/20 0.43
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
P2RY10 O00398 1/20 0.42
SLC6A4 P31645 1/20 0.41
LPAR2 Q9HBW0 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8727046 0.84 MAOA (0.40) MAOAMAOBSLC6A4
SCHEMBL8727045 0.84 SLC6A2 (0.43) MAOAMAOBSLC6A4
SCHEMBL8727042 0.84 SLC6A2 (0.43) MAOAMAOBSLC6A4
SCHEMBL8759440 0.84 MAOA (0.47) MAOAMAOBP2RY10SLC6A4
SCHEMBL8758199 0.83 S1PR1 (0.50) S1PR1S1PR3S1PR4S1PR5S1PR2
SCHEMBL8729121 0.83 S1PR1 (0.50) S1PR1S1PR3S1PR4S1PR5S1PR2
SCHEMBL10084809 0.77 SLC6A4 (0.61) MAOAMAOBSLC6A4
SCHEMBL8634784 0.77 SLC6A4 (0.47) SLC6A4
SCHEMBL8634785 0.77 SLC6A4 (0.47) SLC6A4
SCHEMBL8634781 0.77 SLC6A4 (0.47) SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5726165-A HYPOGLYCEMIC AGENTS; DIETETICS; GASTROINTESTINAL DISORDERS SMITHKLINE BEECHAM P.L.C. (GB) 1998-03-10 US disclosed
EP-0772585-A1 ARYLOXY AND ARYLTHIOPROPANOLAMINE DERIVATIVES USEFUL AS BETA 3-ADRENORECEPTOR AGONISTS AND ANTAGONISTS OF THE BETA 1 AND BETA 2-ADRENORECEPTORS AND PHARMACEUTICAL COMPOSITION THEREOF SMITHKLINE BEECHAM PLC (GB) 1997-05-14 EP disclosed
WO-1996004233-A1 ARYLOXY AND ARYLTHIOPROPANOLAMINE DERIVATIVES USEFUL AS BETA 3-ADRENORECEPTOR AGONISTS AND ANTAGONISTS OF THE BETA 1 AND BETA 2-ADRENORECEPTORS AND PHARMACEUTICAL COMPOSITION THEREOF SMITHKLINE BEECHAM PLC (GB) 1996-02-15 WO disclosed